Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals
- PMID: 18401577
- DOI: 10.1007/s00228-008-0477-7
Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals
Abstract
Background: More than 380,000 angiographic procedures are performed every year in Italian hospitals, with an increase rate of 8% per year. Although contrast media (CM) are considered relatively safe, adverse drug reactions (ADRs) remain an important issue.
Objectives: The objective of this study was to quantify the incidence of immediate and delayed nonrenal ADRs to iodinated CM in an Italian cohort and to evaluate whether their different physicochemical properties are able to affect the incidence of immediate or delayed ADRs.
Methods: A prospective intensive monitoring study was conducted on a cohort of patients undergoing radiodiagnostic procedures with iodinated CM enrolled in two hospitals in Tuscany, Italy. To evaluate both immediate (within 1 h after CM administration) and delayed (>1 h to 1 week after CM administration) ADRs to CM, two questionnaires were administered. Adverse events (AEs) were analyzed to check the causality assessment between CM and ADR. If more than one symptom occurred in the same patient, they were treated as a single event.
Results: One thousand five hundred and fourteen subjects who were exposed to iodinated CM completed the questionnaires. Mean age [standard deviation (SD)] was 65.4 (13.3) years, and 57.9% were male patients. A total of 178 [11.8%; 95% confidence interval (CI) 10.1-13.4] ADRs were reported. Thirty-four (2.2%; 1.5-3.1) and 144 (9.5%; 8.0-11.1) developed immediate and delayed ADRs, respectively. Both types of ADRs were experienced by six subjects (0.4%; 0.1-0.8). One hundred and seventy-six cases (98.8%; 96.0-99.8) were classified as possible and two (1.1%; 0.1-3.9) as probable ADRs. Monomeric low-osmolal (iopromide, iomeprol, iobitridol) and dimeric iso-osmolal (iodixanol) groups mainly reported delayed allergy-like ADRs of mild severity. Only one immediate reaction was severe. Multivariate analysis confirmed a higher risk of immediate reactions occurring for monomeric CM (OR 4.3; 95% CI 1.2-15.7), whereas the risk of delayed ADRs was significantly higher for the dimeric group (OR 1.8; 1.1-2.5).
Conclusions: Monomeric CM were more frequently involved in immediate ADRs, whereas dimeric CM were involved in delayed reactions. Although severe life-threatening ADRs to CM were confirmed to be rare, due to the large use of these drugs, they still retain clinical and epidemiological significance.
Comment in
-
Contrast-media-induced hypersensitivity or allergic/allergic-like reactions? Suggestion for a more appropriate use of the nomenclature.Eur J Clin Pharmacol. 2008 Sep;64(9):931-2; author reply 933-4. doi: 10.1007/s00228-008-0527-1. Epub 2008 Aug 6. Eur J Clin Pharmacol. 2008. PMID: 18682923 No abstract available.
Similar articles
-
Safety of non-ionic contrast media in CT examinations for out-patients: retrospective multicenter analysis of 473,482 patients.Eur Radiol. 2024 Sep;34(9):5570-5577. doi: 10.1007/s00330-024-10654-2. Epub 2024 Mar 8. Eur Radiol. 2024. PMID: 38457038
-
Differences in Adverse Reactions Among Iodinated Contrast Media: Analysis of the KAERS Database.J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2205-2211. doi: 10.1016/j.jaip.2019.02.035. Epub 2019 Mar 12. J Allergy Clin Immunol Pract. 2019. PMID: 30877072
-
Varied incidence of immediate adverse reactions to low-osmolar non-ionic iodide radiocontrast media used in computed tomography.Clin Exp Allergy. 2017 Jan;47(1):106-112. doi: 10.1111/cea.12803. Epub 2016 Oct 12. Clin Exp Allergy. 2017. PMID: 27648932
-
Incidence and severity of nonionic low-osmolar iodinated contrast medium-related adverse drug reactions in the Republic of Korea: Comparison by generic.Medicine (Baltimore). 2023 May 12;102(19):e33717. doi: 10.1097/MD.0000000000033717. Medicine (Baltimore). 2023. PMID: 37171360 Free PMC article.
-
Contrast media and cutaneous reactions. Part 2: Delayed hypersensitivity reactions to iodinated contrast media.Clin Exp Dermatol. 2019 Dec;44(8):844-860. doi: 10.1111/ced.13991. Epub 2019 Jun 4. Clin Exp Dermatol. 2019. PMID: 31162717 Review.
Cited by
-
Late adverse reactions to intravascular iodine based contrast media: an update.Eur Radiol. 2011 Nov;21(11):2305-10. doi: 10.1007/s00330-011-2200-9. Epub 2011 Jul 16. Eur Radiol. 2011. PMID: 21779853
-
Intensive Monitoring Studies for Assessing Medicines: A Systematic Review.Front Med (Lausanne). 2019 Jul 19;6:147. doi: 10.3389/fmed.2019.00147. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31380375 Free PMC article.
-
Potential drug-drug interactions and radiodiagnostic procedures: an in-hospital survey.Pharm World Sci. 2010 Apr;32(2):200-5. doi: 10.1007/s11096-010-9370-4. Epub 2010 Feb 5. Pharm World Sci. 2010. PMID: 20135228
-
Induction of upregulation and downregulation of the T-cell activation marker CD98 in patients undergoing contrast-enhanced CT with iodinated non-ionic dimeric contrast medium.Korean J Radiol. 2009 Jan-Feb;10(1):58-62. doi: 10.3348/kjr.2009.10.1.58. Korean J Radiol. 2009. PMID: 19182504 Free PMC article.
-
The incidence of skin lesions in contrast media-induced chemical hypersensitivity.Exp Ther Med. 2019 Feb;17(2):1113-1124. doi: 10.3892/etm.2018.7056. Epub 2018 Dec 5. Exp Ther Med. 2019. PMID: 30679982 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials